Has Diana Burns received payments from drug or device companies?

Yes. Drug and device makers reported $2,510 in general payments to Diana Burns across 132 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Diana Burns did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Diana Burns come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Diana Burns

Nurse Practitioner · Portsmouth, OHNPI 1598197162

Payments from drug & device makers

$2,510in general payments, 2019–2025

Across 132 payments — averaging $19.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$947
Alkermes, Inc.$236
Axsome Therapeutics, Inc.$202
Gilead$176
Otsuka America Pharmaceutical, Inc.$135
Teva Pharmaceuticals USA, Inc.$121
plus $692 from 15 others

What the payments were for

Food & beverage$2,510100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	57	$947
Alkermes, Inc.	11	$236
Axsome Therapeutics, Inc.	6	$202
Gilead	11	$176
Otsuka America Pharmaceutical, Inc.	8	$135
Teva Pharmaceuticals USA, Inc.	7	$121
Novo Nordisk	1	$113
Vanda Pharmaceuticals Inc.	4	$100
Neurocrine Biosciences, Inc.	4	$81
Braeburn Inc.	4	$57
E.r. Squibb & Sons, L.L.C.	2	$56
Indivior Inc.	3	$56
Johnson & Johnson	2	$46
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$38
Lilly USA, LLC	2	$32
Supernus Pharmaceuticals, Inc.	2	$31
Xeris Pharmaceuticals, Inc.	2	$26
Organon	1	$16
Biohaven Pharmaceuticals, Inc.	1	$15
Orexo US, Inc.	1	$14
Sanofi-aventis U.S. LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

RYBELSUS$113
VRAYLAR$110

How this compares

$2,510 in reported general payments places this provider in the 90th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
BrixadiBuprenorphine	11	$16,861
Oxcarbazepine	38	$1,277
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	13	$926
Albuterol Sulfate HfaAlbuterol Sulfate	19	$561
Ibuprofen	26	$202
Quetiapine Fumarate	18	$181
Propranolol Hcl	15	$172
Fluoxetine Hcl	13	$140
Amitriptyline Hcl	22	$122
Lisinopril	40	$101
Naproxen	16	$101
Buspirone Hcl	11	$89
Clonidine Hcl	30	$89
Acyclovir	12	$55
Pantoprazole Sodium	16	$49

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Braeburn Inc.Brixadi	$57	$16,86111 claims
Teva Pharmaceuticals USA, Inc.Acyclovir	$121	$5512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Portsmouth

Margaret BobonichCleveland$235K
Mary GallagherWestlake$229K
Sonia HissettCincinnati$179K
Ashley TaylorNew Albany$107K
Beth FaimanCleveland$101K
Katherine AlexanderColumbus$99K
Tiffany JonesCincinnati$99K
Kate NewmanWestlake$78K
Daniella GerySouth Euclid$73K
Amy HazelCanton$63K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →